Press review: Manchester terror attack's call to arms and US' push for Assad's ousterPress Review May 24, 13:00
Russian Navy to get seven advanced nuclear submarines by 2021Military & Defense May 24, 12:44
Defense Ministry reports on Russian army's 2016 picksMilitary & Defense May 24, 11:32
Defense minister vows causes of Tu-154 crash near Sochi will be disclosed soonWorld May 24, 11:20
Russia, US discuss Syrian conflict in round-the-clock mode — defense ministerRussian Politics & Diplomacy May 24, 11:01
Russia ready to help countries affected by terrorism in their probe — security chiefRussian Politics & Diplomacy May 24, 10:39
Defense chief names strategically important regions for RussiaRussian Politics & Diplomacy May 24, 10:29
Russian defense contractor develops domestic air traffic control systemMilitary & Defense May 24, 9:45
New radar system enters combat duty in Russia’s Far EastMilitary & Defense May 24, 9:24
ATLANTA and STOCKHOLM, Feb. 4, 2013 /PRNewswire/ -- At an exclusive event scheduled March 1, 2013, Elekta will reveal a leap forward in radiation oncology and the care of individuals with cancer worldwide.
Founded in 1972, Elekta was the first to bring a completely digital linear accelerator to the market, as well as the first to fully integrate imaging technology in the treatment system. Elekta is a market-leading developer of cancer care and neuroscience solutions, including a world-class portfolio of linear accelerators, dedicated radiosurgery and brachytherapy systems and oncology information and treatment planning software solutions.
"At Elekta, we are united by a passion that drives us to constantly strive toward the development of new cancer care solutions that benefit patients, caregivers and healthcare systems," says Elekta's President and CEO Tomas Puusepp. "It is this unrelenting dedication to patients and their healthcare providers that has inspired our efforts to create a truly singular technological solution in radiation oncology."
The worldwide unveiling event will be held Friday, March 1 at the Renaissance Atlanta Waverly Hotel, Atlanta, Georgia, USA, 11 a.m. - 12 p.m. EST. To attend or view live online, register at www.elekta.com.
Elekta is a human care company pioneering significant innovations and clinical solutions for treating cancer and brain disorders. The company develops sophisticated, state-of-the-art tools and treatment planning systems for radiation therapy, radiosurgery and brachytherapy, as well as workflow enhancing software systems across the spectrum of cancer care. Stretching the boundaries of science and technology, providing intelligent and resource-efficient solutions that offer confidence to both healthcare providers and patients, Elekta aims to improve, prolong and even save patient lives.
Today, Elekta solutions in oncology and neurosurgery are used in over 6,000 hospitals worldwide. Elekta employs around 3,400 employees globally. The corporate headquarters is located in Stockholm, Sweden, and the company is listed on the Nordic Exchange under the ticker EKTAb.